ISSN:
1365-4632
Source:
Blackwell Publishing Journal Backfiles 1879-2005
Topics:
Medicine
Notes:
A 32-year-old man was seen in January 1997 for a skin eruption which had appeared 2 months earlier. He was in good health and was not taking any drugs. He had not left town and denied any other symptom except a short, flu-like episode 2 months earlier.On examination, he showed multiple, papular, scaly and necrotic lesions over the trunk, arms ( 〈link href="#f1"/〉), and thighs. The face and the mucosae were spared. No lymphadenopathy was evident, and the liver and spleen were not palpable.〈figure xml:id="f1"〉1〈mediaResource alt="image" href="urn:x-wiley:00119059:IJD670:IJD_670_f1"/〉Scaly and necrotic papules on the armRoutine laboratory tests were insignificant. Histopathology of a papular lesion of the arm showed a thick scaly crust overlying a necrotic epidermis and a lichenoid infiltrate of lymphocytes and neutrophils ( 〈link href="#f2"/〉). Extravasation of red blood cells and endothelial swelling of the small superficial vessels were also present.〈figure xml:id="f2"〉2〈mediaResource alt="image" href="urn:x-wiley:00119059:IJD670:IJD_670_f2"/〉Histopathology showing a lichenoid infiltrate of lymphocytes and neutrophils with a thick scaly crust and necrosis of the epidermis (hematoxylin and eosin, ×100)A diagnosis of subacute pityriasis lichenoides (PL) was made, and treatment with 500 mg/day azithromycin, 3 days a week for 1 month, was prescribed without any benefit. Enzyme-linked immunosorbent assay (ELISA) for Toxoplasma gondii showed immunoglobulin G (IgG) 150 (n.v. 〈10) and IgM 1.35 (n.v. 〈0.65). Diagnosis of recent toxoplasmosis prompted an ocular examination which excluded any eye involvement.A specific treatment with spiramycin, 3,000.000 U twice a day for 2 months, was given. The patient underwent a complete resolution of skin lesions which healed leaving atrophic and hyperpigmentary signs ( 〈link href="#f3"/〉). At the end of therapy, ELISA was still positive for both IgG and IgM. Spiramycin was changed to trimethoprim–sulfamethoxazole, 800–160 mg twice a day, which was continued for 2 months.〈figure xml:id="f3"〉3〈mediaResource alt="image" href="urn:x-wiley:00119059:IJD670:IJD_670_f3"/〉Clearing of the PL after specific anti-Toxoplasma therapyReactive serology persisted for both IgG and IgM for 8 months, but no new lesions developed.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1046/j.1365-4362.1999.00670.x
Permalink